Health Trials

Untreated Advanced or Recurrent Thymic Carcinomas

1

Review clinical trials related to Untreated Advanced or Recurrent Thymic Carcinomas. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)

A phase II, investigator-initiated, non-randomized, open-label, single-arm, multicenter study to evaluate the efficacy and safety of Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab combination for previously untreated advanced or recurrent thymic carcinomas

Participants needed: 35
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: National Cancer Center, JapanUpdated: Oct 23, 2023Locations: 1
Eligibility criteria

Patients aged 18 years or older at the time of informed consent, who are patholo... [+14]

Has diagnosed as thymomas [+35]

Read more